| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Neuland Laboratories Limited (NSE: NEULANDLAB)
NEULANDLAB Technical Analysis
5
| As on 30th Apr 2024 NEULANDLAB SHARE Price closed @ 7593.45 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 4775.45 & Strong Buy for SHORT-TERM with Stoploss of 6721.48 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NEULANDLABSHARE Price
| Open | 7215.70 | Change | Price | % |
| High | 7625.00 | 1 Day | 395.35 | 5.49 |
| Low | 7215.70 | 1 Week | 56.65 | 0.75 |
| Close | 7593.45 | 1 Month | 1271.30 | 20.11 |
| Volume | 46474 | 1 Year | 5454.30 | 254.98 |
| 52 Week High 4290.50 | 52 Week Low 973.40 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.20 | -1.86% |
| YESBANK | 26.15 | -3.51% |
| NHPC | 96.20 | 3.00% |
| PNB | 141.05 | 2.77% |
| IDFCFIRSTB | 82.15 | 0.61% |
| RECLTD | 507.15 | 9.54% |
| IOC | 168.85 | -4.47% |
| MAHABANK | 70.10 | -1.34% |
| HFCL | 100.50 | 2.60% |
| TATASTEEL | 165.00 | -1.43% |
NSE INDIA Top Gainers Stocks
| HISARMETAL | 222.00 | 20.00% |
| WILLAMAGOR | 40.95 | 19.91% |
| NGIL | 61.65 | 15.67% |
| LIKHITHA | 351.20 | 12.80% |
| COMPUSOFT | 36.45 | 11.98% |
| PDMJEPAPER | 83.50 | 11.71% |
| BFUTILITIE | 862.25 | 10.74% |
| POWERINDIA | 9578.75 | 10.53% |
| IRIS | 155.15 | 10.00% |
| HINDMOTORS | 34.65 | 10.00% |
NSE INDIA Top Losers Stocks
| NEULANDLAB Daily Charts |
NEULANDLAB Intraday Charts |
Whats New @ Bazaartrend |
NEULANDLAB Free Analysis |
|
|
NEULANDLAB Important Levels Intraday
| RESISTANCE | 8382.17 |
| RESISTANCE | 8129.22 |
| RESISTANCE | 7972.87 |
| RESISTANCE | 7816.52 |
| SUPPORT | 7370.38 |
| SUPPORT | 7214.03 |
| SUPPORT | 7057.68 |
| SUPPORT | 6804.73 |
NEULANDLAB Target May 2024
| 4th UP Target | 11155.4 |
| 3rd UP Target | 9908.82 |
| 2nd UP Target | 9138.31 |
| 1st UP Target | 8367.79 |
| 1st DOWN Target | 6169.21 |
| 2nd DOWN Target | 5398.69 |
| 3rd DOWN Target | 4628.18 |
| 4th DOWN Target | 3381.64 |
NEULANDLAB Weekly Target
| 4th UP Target | 8714.35 |
| 3rd UP Target | 8156.02 |
| 2nd UP Target | 7810.90 |
| 1st UP Target | 7465.78 |
| 1st DOWN Target | 6481.02 |
| 2nd DOWN Target | 6135.90 |
| 3rd DOWN Target | 5790.78 |
| 4th DOWN Target | 5232.45 |
NEULANDLAB Target2024
| 4th UP Target | 13811 |
| 3rd UP Target | 11078.8 |
| 2nd UP Target | 9389.85 |
| 1st UP Target | 7700.95 |
| 1st DOWN Target | 2881.85 |
| 2nd DOWN Target | 1192.95 |
| 3rd DOWN Target | -495.95 |
| 4th DOWN Target | -3228.25 |
Neuland Laboratories Limited ( NSE INDIA Symbol : NEULANDLAB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NEULANDLAB Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is Below 20 | Over Sold | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 334.00 | |
| 10 Day Avg Volume | Traded 28.18 % More then 10 Day Average Volume | ||
NEULANDLAB Other Details
| Segment | EQ | |
| Market Capital | 21544845312.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
NEULANDLAB Address
 |
||
NEULANDLAB Latest News
NEULANDLAB Business Profile
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, central nervous system, fluoroquinolones, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was incorporated in 1984 and is headquartered in Hyderabad, India. Address: Phoenix IVY Building, Hyderabad, India, 500033
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service